Medtronic’s ICM Proves Cost-Effective In Preventing Recurrent Stroke
Executive Summary
A new study shows implantable cardiac monitors are a cost-effective tool for preventing recurrent strokes following a stroke suspected to be caused by atrial fibrillation.
You may also be interested in...
Cardiologs’ AI Trial Demonstrates Effectiveness Of Remote ECG Monitoring
Cardiologs has completed a clinical trial ECG analysis platform with implantable loop recorders. It can remotely identify features that have previously been a burden to physicians.
Medtronic Sponsors ALLEVIATE HF Remote Heart Failure Monitor
The randomized trial will evaluate the ability of the Reveal LINQ insertable monitor to help physicians prevent the progression of heart failure.
FDA Clears Medtronic's And Boston Scientific's Remote Cardiac Monitors, Approves Abbott’s Bluetooth-Compatible ICDs
Medtronic will launch the LINQ II remotely programmable, insertable cardiac monitor in the US and Europe this summer following FDA clearance. Boston Scientific plans to launch its LUX-Dx monitor later this year. The agency also approved Abbott's Gallant ICD and CRT-D devices, which communicate with Abbott's myMerlinPulse mobile app.